My Profile   |   Print Page   |   Contact Us   |   Sign In   |   Register
ASAP Blog
Blog Home All Blogs
Welcome to ASAP Blog, the best place to stay current regarding upcoming events, member companies, the latest trends, and leaders in the industry. Blogs are posted at least once a week; members may subscribe to receive notifications when new blogs are posted by clicking the "Subscribe" link above.

 

Search all posts for:   

 

Top tags: alliance management  alliances  collaboration  partnering  alliance  partners  alliance managers  partner  alliance manager  partnerships  ecosystem  The Rhythm of Business  partnership  Jan Twombly  governance  biopharma  Strategic Alliance Magazine  Eli Lilly and Company  Vantage Partners  IoT  strategy  ASAP BioPharma Conference  healthcare  IBM  NetApp  2015 ASAP Global Alliance Summit  Cisco  communication  innovation  Strategic Alliances 

Former FDA Head: Complex Drugs Require Closer Collaboration Between Biotechs, Medical Devices Companies

Posted By Administration, Friday, June 20, 2014
Originally posted on 4/12/2013

Former head of the U.S. Food and Drug Administration Dr. Andrew von Eschenbach, who served in this capacity from 2005 to 2009, had some interesting things to say about the changing nature of drug development in early clinical stages. According to the Boston Business Journal, "Von Eschenbach stressed that the medical industry is at an inflection point, due to rapid advancement in recent years in understanding how cells and cell nuclei work. But as the types of medical conditions and diseases that are being targeted are more complex, the solutions needed to address them go beyond a simple drug or medical device. And that means companies working together much more than current intellectual property laws allows.

'You need to be collaborating and sharing intellectual property at the very outset,' he said. 'Today, there are huge barriers to doing that.'”

In the full Boston Business Journal article, von Eschenbach is said to have suggested regulatory changes and an overhaul in funding models to facilitate this type of collaboration. However, one has to wonder whether medical device companies and biotechs have the collaboration skills to execute effectively, even if von Eschenbach's recommendations were implemented.

This week, we put the editorial content for the Q2 2013 issue of Strategic Alliance Magazine to bed. During the course of putting our cover story on big company/small company alliances together, we were reminded that biotechs oftentimes need the larger company to guide them through working with alliance governance processes and such—not always, mind you, but it is common for the smaller entity to follow Big Pharma's lead. When you talk about a biotech–medical device collaboration, now you can conceivably have two alliance novices, which could lead to less-than-optimal execution of combination drug-medical device products.

Is this a real concern? We'd love to hear from the folks from the biopharma side.

This post has not been tagged.

Share |
PermalinkComments (0)
 

Alliance Excellence Award Honorees Benefit ASAP Community as Much as the Winners Themselves

Posted By Administration, Friday, June 20, 2014
Originally posted on 4/11/2013

As many in the ASAP community know by now, the association unveiled its Alliance Excellence Award winners during the 2013 ASAP Global Alliance Summit, held last month in Orlando, Fla. ASAP board member Alistair Pim, CSAP, vice president of global strategic alliances at Schneider Electric, recently used the two awards his company received this year to talk about the greater purpose the honors—and ASAP membership itself—serve for Schneider.

Pim acknowledged the great satisfaction the two diamond-shaped trophies bring to the internal alliance teams, which have now seen their efforts validated in a big way. However, he also made the point that self-promotion is not the awards’ main value proposition.

“Rather, it’s to make the point that we are committed to excellence in alliance management,” he wrote.

In the beginning of the post, Pim illustrated the role ASAP has played in this commitment—most notably, through best-practice sharing with the community and Global Summit attendance year after year. By engaging in the process of nominating and winning an Alliance Excellence Award, and then promoting the story well after the Summit, the alliance management community gets an opportunity to learn from Schneider the way Schneider has learned from them over the years. In many ways, this reciprocal exchange of challenges and the solutions that overcome them is what the Alliance Excellence Awards, the ASAP Global Alliance Summit, and ASAP itself are all about.

Read more about Schneider’s two awards and what they mean to the company. Hopefully you, too, will be inspired to trumpet your great success story and help others tackle the obstacles you faced—and conquered.

This post has not been tagged.

Share |
PermalinkComments (0)
 

Rexel Partnership with Schneider Electric Recognized

Posted By Administration, Friday, June 20, 2014
Originally posted on 4/10/2013

Rexel -- a global leader in the distribution of sustainable and innovative products and services for automation, technical supply and energy management -- was one of the partners recognized in an award given to Schneider Electric for its alliance management capabilities in corporate social responsibility at the 2013 annual summit of the Association of Strategic Alliance Professionals (ASAP) held in Orlando, Florida in the USA in March.

This post has not been tagged.

Share |
PermalinkComments (0)
 

SAS-Teradata "Legion of Analytic Superheroes" Effort Lands Industry Award

Posted By Administration, Friday, June 20, 2014
Originally posted on 4/10/2013

SAS and Teradata had some fun creating their "Legion of Analytic Heroes" last year to promote their data partnership. But the effort was no joke in the eyes of the Association of Strategic Alliance Professionals, which picked SAS and Teradata for an ASAP award.

This post has not been tagged.

Share |
PermalinkComments (0)
 

Sanofi Turns to Schneider Electric to Save Energy Costs in Manufacturing

Posted By Administration, Friday, June 20, 2014
Originally posted on 4/3/2013

In a deal between two ASAP Global Members last week, Sanofi and Schneider Electric signed a three-year agreement to collaborate on making the former's manufacturing sites more energy efficient. Sanofi will work with Schneider to monitor energy usage, forecast energy price changes, and build in energy-efficient designs into new facilities.

Perhaps Schneider will use this deal will be a model for future discussions with other Big Pharma multinationals at the 2013 ASAP BioPharma Conference or next year's ASAP Global Alliance Summit?

This post has not been tagged.

Share |
PermalinkComments (0)
 
Page 71 of 83
 |<   <<   <  66  |  67  |  68  |  69  |  70  |  71  |  72  |  73  |  74  |  75  |  76  >   >>   >| 
For more information email us at info@strategic-alliances.org or call +1-781-562-1630